ZA942119B - Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives - Google Patents

Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives

Info

Publication number
ZA942119B
ZA942119B ZA942119A ZA942119A ZA942119B ZA 942119 B ZA942119 B ZA 942119B ZA 942119 A ZA942119 A ZA 942119A ZA 942119 A ZA942119 A ZA 942119A ZA 942119 B ZA942119 B ZA 942119B
Authority
ZA
South Africa
Prior art keywords
phenylglycinamides
acid derivatives
phenylacetic acid
substituted phenylacetic
heterocyclically substituted
Prior art date
Application number
ZA942119A
Inventor
Ulrich Mueller
Juergen Dr Dressel
Peter Dr Fey
Rudolf H Dr Hanko
Walter Dr Huebsch
Thomas Dr Kraemer
Matthias Dr Mueller-Gliemann
Martin Dr Beuck
Stanislav Prof Dr Kazda
Stefan Dr Wohlfeil
Andreas Dr Knorr
Johannes-Peter Dr Stasch
Siegfried Dr Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA942119B publication Critical patent/ZA942119B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA942119A 1993-03-26 1994-03-25 Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives ZA942119B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4309968A DE4309968A1 (en) 1993-03-26 1993-03-26 Phenylglycinamides of heterocyclic substituted phenylacetic acid derivatives

Publications (1)

Publication Number Publication Date
ZA942119B true ZA942119B (en) 1994-11-07

Family

ID=6484001

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942119A ZA942119B (en) 1993-03-26 1994-03-25 Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives

Country Status (15)

Country Link
EP (1) EP0622358A1 (en)
JP (1) JPH06329637A (en)
KR (1) KR940021532A (en)
CN (1) CN1102645A (en)
AU (1) AU5788694A (en)
CA (1) CA2119669A1 (en)
CZ (1) CZ71094A3 (en)
DE (1) DE4309968A1 (en)
FI (1) FI941380A (en)
HU (1) HUT68514A (en)
IL (1) IL109093A0 (en)
NO (1) NO941073L (en)
NZ (1) NZ260163A (en)
SK (1) SK35094A3 (en)
ZA (1) ZA942119B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2219944A1 (en) * 1995-05-19 1996-11-21 Miho Kobayashi 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors
DE19613550A1 (en) * 1996-04-04 1997-10-09 Bayer Ag New pyrimido [1,2-a] indoles
EP0802192A1 (en) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclic-substituted phenylglycinolamides with antiatheroschlerotic activity and process for their production
DE19619950A1 (en) 1996-04-17 1997-10-23 Bayer Ag Heterocyclic substituted phenylglycinolamides
DE19615265A1 (en) * 1996-04-18 1997-12-04 Bayer Ag New pyridazino, pyrimido, pyrazino and triazinoindoles
EP1013273A1 (en) * 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
CZ293257B6 (en) * 1998-12-23 2004-03-17 Novartis Ag Pharmaceutical preparation containing AT-1 receptor antagonist for treating diseases associated with an increase of AT-1 in the sub-epithelial area

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200954A1 (en) * 1991-04-26 1992-10-29 Bayer Ag New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
DE4208051A1 (en) * 1992-03-13 1993-09-16 Bayer Ag SUBSTITUTED PHENYL ACIDIC ACID AMIDE

Also Published As

Publication number Publication date
KR940021532A (en) 1994-10-19
CA2119669A1 (en) 1994-09-27
NO941073D0 (en) 1994-03-24
FI941380A0 (en) 1994-03-24
DE4309968A1 (en) 1994-09-29
JPH06329637A (en) 1994-11-29
FI941380A (en) 1994-09-27
CZ71094A3 (en) 1994-10-19
HU9400865D0 (en) 1994-06-28
HUT68514A (en) 1995-06-28
EP0622358A1 (en) 1994-11-02
NO941073L (en) 1994-09-27
AU5788694A (en) 1994-09-29
NZ260163A (en) 1996-02-27
IL109093A0 (en) 1994-06-24
CN1102645A (en) 1995-05-17
SK35094A3 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
AU3105493A (en) Quinolone- and naphthyridone-carboxylic acid derivatives
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
PL306127A1 (en) Derivatives of epi-epibathydine
AU616819B2 (en) Beta-amino-boronic acid derivatives
HU9400143D0 (en) Quinolon-and naphtiridon-carboxylic acid derivatives
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
AU3150289A (en) Heterocyclic substituted dihaloisonicotinic acid amide derivatives
ZA93190B (en) Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives
AU6892291A (en) 4-hydroxyquinaldic acid derivatives
AU673895B2 (en) Heterocyclic iminobismethylenebisphosphonic acid derivatives
HU9403116D0 (en) Epoxy-succinic acid derivatives
AU5188093A (en) Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
ZA942119B (en) Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
GB9525828D0 (en) Use of hetarylacetic acid derivatives
ZA931367B (en) Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives
ZW7994A1 (en) 2-oximino-2-thienyl-acetic acid derivatives
ZA941923B (en) Phenoxyphenylacetic acid derivatives
ZA93125B (en) Quinolone- and naphthyridone-carboxylic acid derivatives
BG98366A (en) Derivatives of nicotinic acid
AU5517890A (en) Mevinic acid derivatives
AU5005990A (en) Substituted phenoxyphenylpropionic acid derivatives
GB9306454D0 (en) Heterocyclic acid derivatives
GB9325609D0 (en) Heterocyclic acid derivatives